102 related articles for article (PubMed ID: 15890569)
1. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.
Galloway TJ; Zhang QE; Nguyen-Tan PF; Rosenthal DI; Soulieres D; Fortin A; Silverman CL; Daly ME; Ridge JA; Hammond JA; Le QT
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):362-371. PubMed ID: 27478170
[TBL] [Abstract][Full Text] [Related]
3. Regarding the role of HER2 overexpression on the survival in muscle-invasive bladder cancer.
Yang W; Liu J
Int J Surg; 2024 Apr; 110(4):2466. PubMed ID: 38241347
[No Abstract] [Full Text] [Related]
4. The values of HER-2 expression in the non-muscle-invasive bladder cancer: a retrospective clinical study.
Wang S; Ji Y; Liu Y; Du P; Ma J; Yang X; Yu Z; Yang Y
Front Oncol; 2023; 13():1243118. PubMed ID: 38090493
[TBL] [Abstract][Full Text] [Related]
5. Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy.
Warli SM; Prapiska FF; Siregar DIS; Seja IA
World J Oncol; 2023 Oct; 14(5):423-429. PubMed ID: 37869246
[TBL] [Abstract][Full Text] [Related]
6. Current therapeutic strategies for invasive and metastatic bladder cancer.
Vishnu P; Mathew J; Tan WW
Onco Targets Ther; 2011; 4():97-113. PubMed ID: 21792316
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer.
Miyamoto DT; Mouw KW; Feng FY; Shipley WU; Efstathiou JA
Lancet Oncol; 2018 Dec; 19(12):e683-e695. PubMed ID: 30507435
[TBL] [Abstract][Full Text] [Related]
8. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.
Dahl DM; Karrison TG; Michaelson MD; Pham HT; Wu CL; Swanson GP; Shipley WU; Vuky J; Lee RJ; Zietman AL; Souhami L; Chang BK; Deming RL; Ellerton JA; Sandler HM; Rodgers JP; Feng FY; Efstathiou JA
Eur Urol Oncol; 2024 Feb; 7(1):83-90. PubMed ID: 37442672
[TBL] [Abstract][Full Text] [Related]
10. Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy.
Marcq G; Evaristo G; Kool R; Shinde-Jadhav S; Skowronski R; Mansure JJ; Souhami L; Cury F; Brimo F; Kassouf W
Eur Urol Open Sci; 2022 Sep; 43():14-21. PubMed ID: 36353066
[TBL] [Abstract][Full Text] [Related]
11. HER2 expression in urothelial carcinoma, a systematic literature review.
Scherrer E; Kang A; Bloudek LM; Koshkin VS
Front Oncol; 2022; 12():1011885. PubMed ID: 36338710
[TBL] [Abstract][Full Text] [Related]
12. Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway.
Kao CC; Cheng YC; Yang MH; Cha TL; Sun GH; Ho CT; Lin YC; Wang HK; Wu ST; Way TD
Environ Toxicol; 2021 Nov; 36(11):2186-2195. PubMed ID: 34291863
[TBL] [Abstract][Full Text] [Related]
13. Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine.
Kamran SC; Efstathiou JA
Front Oncol; 2021; 11():675311. PubMed ID: 34026653
[TBL] [Abstract][Full Text] [Related]
14. Bladder preservation: Translating discovery for clinical impact in urothelial cancer.
Miyamoto DT; Abbosh PH; West CML; Mouw KW
Urol Oncol; 2021 Apr; 39(4):201-208. PubMed ID: 33257220
[TBL] [Abstract][Full Text] [Related]
15. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
Jiang DM; Chung P; Kulkarni GS; Sridhar SS
Curr Oncol Rep; 2020 Feb; 22(2):14. PubMed ID: 32008105
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Factor-κB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer.
Chiang Y; Wang CC; Tsai YC; Huang CY; Pu YS; Lin CC; Cheng JC
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31766169
[TBL] [Abstract][Full Text] [Related]
17. Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.
Davis HW; Vallabhapurapu SD; Chu Z; Vallabhapurapu SL; Franco RS; Mierzwa M; Kassing W; Barrett WL; Qi X
Oncotarget; 2019 Jan; 10(8):856-868. PubMed ID: 30783515
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 Years.
Raghavan D
Bladder Cancer; 2015 Apr; 1(1):3-13. PubMed ID: 30561439
[TBL] [Abstract][Full Text] [Related]
19. Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
Gerke T; Beltran H; Wang X; Lee GM; Sboner A; Karnes RJ; Klein EA; Davicioni E; Yousefi K; Ross AE; Börnigen D; Huttenhower C; Mucci LA; Trock BJ; Sweeney CJ
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):584-590. PubMed ID: 30420441
[TBL] [Abstract][Full Text] [Related]
20. Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy.
El-Achkar A; Souhami L; Kassouf W
Curr Urol Rep; 2018 Nov; 19(12):108. PubMed ID: 30392150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
